Looking back, Otto remembers struggling to breathe when he was as young as four. Exertion would make him cough, and the coughing fits would go on and on. Growing up in a family of eight children in a village in northern Uganda, ...
Feb 12, 2019
0
8
An international collaboration including Javier Belda, professor of surgery at the University of Valencia, has reported a new genetic variant associated with acute respiratory distress syndrome (ARDS). The work, with a sample ...
Jan 28, 2019
0
1
Researchers from Skoltech (Maxim Fedorov's group, CDISE) and the German Research Center for Environmental Health, Helmholtz Zentrum München (HMGU; Igor Tetko's group) have developed an enhanced drug candidate toxicity prediction ...
Jan 25, 2019
0
7
Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. The trial is being conducted at the Saint Louis University ...
Jan 23, 2019
0
1
The first research showing that VSV-ZEBOV vaccine could help protect against Ebola brought sighs of relief. It was an incredible and humbling achievement that had only been possible due to the global collaboration of researchers, ...
Dec 7, 2018
0
1
Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and monkeys from the infection.
Dec 4, 2018
0
96
The Walter Reed Army Institute of Research (WRAIR) this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Oct 15, 2018
0
27
A novel synthetic DNA vaccine developed based on technology pioneered by scientists at The Wistar Institute Vaccine & Immunotherapy Center offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical ...
Oct 10, 2018
0
12
A fine line exists between confidence and arrogance, and many in positions of power —such as politicians and CEOs—often are labeled arrogant. Although confidence can serve as both a blessing and a curse, new research ...
Sep 26, 2018
0
0
Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...
Aug 16, 2018
0
0
